Anticoccidial Drugs Market Insights
In April 2019, Creative Diagnostics developed anticoccidial drug assay products to test anticoccidial drug residues in animals. This advancement and awareness of anticoccidial drugs will impact the trend of the anticoccidial drugs market. Growing awareness of animal health and zootonic diseases is expected to increase acceptance of anticoccidial drugs. The rising carnivorous population and reliance on bovine products is expected to be a driving factor for the growth of the anticoccidial drugs market. Additionally, the increase in research and development of veterinary drugs is expected to provide growth opportunities for anticoccidial drugs.
The growth of the global anticoccidial drugs market is expected to be driven by increasing outbreaks of coccidia combined with growing reliance on poultry products. Additionally, stringent government regulations aimed at maintaining livestock health in developed countries are expected to increase the adoption of anticoccidial drugs. Growing expenditure and pet owners' awareness of animal health is expected to be a driving force for the anticoccidial drugs market.
Conversely, certain government policies restricting the use of anticoccidial antimicrobial drugs in livestock are expected to inhibit the growth of the anticoccidial drugs market. Additionally, the growing demand for antibiotic-free meat has likely impacted the growing trend of the anticoccidial drugs market.
Anticoccidial Drugs Market Segment Analysis
By Drug Type
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
By Animal Type
Poultry
Swine
Cattle
Others
Competitive Key Players
Bayer Animal Healthcare
Boehringer Ingelheim
Ceva Animal Health Inc.
Elanco Animal Health (a subsidiary of Eli Lilly)
Merck
Merial
Virbac
Zoetis Animal Healthcare
Vetoquinol SA
Anticoccidial Drugs Market Geographical Analysis
The global anticoccidial drugs market has been segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Developed countries in North America and Europe are estimated to dominate the global anticoccidiosis drug market due to established veterinary care and active government involvement in farm animal health and management. Asia-Pacific and Latin America countries are expected to register higher CAGR in the global anticoccal drugs market growth due to growing dependence on farm animals and an increasing number of pet owners of the company. In the Middle East and Africa, the unmet need for animal health is expected to be a driver of the anticoccal drugs market in the region.
Anticoccidial Drugs Market Key Developments
-
In 2014, Zoetis announced the reintroduction of Zoamix, a synthetic anticoccidial drug indicated for poultry.
-
In February 2015, Zoetis announced the completion of its acquisition of Abbott's animal health business.
-
In May 2016, Laboratorios Hipra received European Union approval for the company's coccidiosis vaccine Evalon